Knockdown of TRB3 induces apoptosis in human lung adenocarcinoma cells through regulation of Notch 1 expression

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 47-52

  Zhou, Hui ^a,b   Luo, Y I ^a   Chen, Jian Hua ^a   Hu, Jun ^a   Luo, Yong Zhong ^a   Wang, Wei ^a   Zeng, Yong ^a   Xiao, Ling ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

A549; Lung cancer; Non small cell lung cancer; Notch 1; Tribbles homolog 3

Indexed keywords

NOTCH1 RECEPTOR; PROTEIN; TRIBBLES HOMOLOG 3; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; PROTEIN EXPRESSION; UPREGULATION;

ADENOCARCINOMA; AGED; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, NOTCH1; REPRESSOR PROTEINS;

MAMMALIA;

EID: 84878945150     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1453     Document Type: Article

References (38)

1. Boudeau J, Miranda-Saavedra D, Barton GJ and Alessi DR: Emerging roles of pseudokinases. Trends Cell Biol 16: 443-452, 2006.
2. Izrailit J, Berman HK, Datti A, Wrana JL and Reedijk M: High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer. Proc Natl Acad Sci USA 110: 1714-1719, 2013.
3. Raja E: Cross-regulation between TGFβ/BMP Signalling and the metabolic LKB1 pathway. Doctoral thesis, Uppsala University, 2012.
4. Bowers AJ, Scully S and Boylan JF: SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia. Oncogene 22: 2823-2835, 2003.
5. Du K, Herzig S, Kulkarni RN and Montminy M: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300: 1574-1577, 2003.
6. Wennemers M, Bussink J, Scheijen B, et al: Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response. Breast Cancer Res 13: R82, 2011.
7. Miyoshi N, Ishii H, Mimori K, et al: Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis. Br J Cancer 101: 1664-1670, 2009.
8. Reedijk M, Odorcic S, Chang L, et al: High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65: 8530-8537, 2005.
9. Lee CW, Raskett CM, Prudovsky I and Altieri DC: Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res 68: 5273-5281, 2008.
10. Leong KG, Niessen K, Kulic I, et al: Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 204: 2935-2948, 2007. (Pubitemid 350179562)
11. Rustighi A, Tiberi L, Soldano A, et al: The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat Cell Biol 11: 133-142, 2009.
12. Shimizu M, Cohen B, Goldvasser P, Berman H, Virtanen C and Reedijk M: Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer. Cancer Res 71: 277-286, 2011.
13. Honjo T: The shortest path from the surface to the nucleus: RBP-J kappa/Su(H) transcription factor. Genes Cells 1: 1-9, 1996.
14. Weijzen S, Rizzo P, Braid M, et al: Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8: 979-986, 2002. (Pubitemid 35033702)
15. Pece S, Serresi M, Santolini E, et al: Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167: 215-221, 2004. (Pubitemid 39435065)
16. Colaluca IN, Tosoni D, Nuciforo P, et al: NUMB controls p53 tumour suppressor activity. Nature 451: 76-80, 2008.
17. Lee CW, Simin K, Liu Q, et al: A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res 10: R97, 2008.
18. Yamaguchi N, Oyama T, Ito E, et al: NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 68: 1881-1888, 2008. (Pubitemid 351416574)
19. Dent R, Trudeau M, Pritchard KI, et al: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13: 4429-4434, 2007. (Pubitemid 47219710)
20. Farnie G and Clarke RB: Mammary stem cells and breast cancer - role of Notch signalling. Stem Cell Rev 3: 169-175, 2007. (Pubitemid 350129719)
21. Yin X, Wolford CC, Chang YS, et al: ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells. J Cell Sci 123: 3558-3565, 2010.
22. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
23. Gavert N and Ben-Ze'ev A: Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14: 199-209, 2008.
24. Timmerman LA, Grego-Bessa J, Raya A, et al: Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18: 99-115, 2004. (Pubitemid 38090691)
25. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME and Moses HL: Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia 6: 603-610, 2004. (Pubitemid 39411098)
26. Sethi N, Dai X, Winter CG and Kang Y: Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer cell 19: 192-205, 2011.
27. Grosshans J and Wieschaus E: A genetic link between morphogenesis and cell division during formation of the ventral furrow in Drosophila. Cell 101: 523-531, 2000.
28. Seher TC and Leptin M: Tribbles, a cell-cycle brake that coordinates proliferation and morphogenesis during Drosophila gastrulation. Curr Biol 10: 623-629, 2000. (Pubitemid 30354697)
29. Sieber C, Kopf J, Hiepen C and Knaus P: Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 20: 343-355, 2009.
30. Hua F, Mu R, Liu J, et al: TRB3 interacts with SMAD3 promoting tumor cell migration and invasion. J Cell Sci 124: 3235-3246, 2011.
31. Matsushima R, Harada N, Webster NJ, Tsutsumi YM and Nakaya Y: Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity. J Biol Chem 281: 29719-29729, 2006. (Pubitemid 44536981)
32. Izrailit J, Berman HK, Datti A, Wrana JL and Reedijk M: High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer. Proc Natl Acad Sci USA 110: 1714-1719, 2013.
33. Xu J, Lv S, Qin Y, et al: TRB3 interacts with CtIP and is overexpressed in certain cancers. Biochim Biophys Acta 1770: 273-278, 2007. (Pubitemid 46019808)
34. Schwarzer R, Dames S, Tondera D, Klippel A and Kaufmann J: TRB3 is a PI 3-kinase dependent indicator for nutrient starvation. Cell Signal 18: 899-909, 2006. (Pubitemid 43208943)
35. Koo SH, Satoh H, Herzig S, et al: PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat Med 10: 530-534, 2004. (Pubitemid 38667913)
36. Ohoka N, Yoshii S, Hattori T, Onozaki K and Hayashi H: TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 24: 1243-1255, 2005. (Pubitemid 40516607)
37. Valastyan S and Weinberg RA: Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275-292, 2011.
38. Weilbaecher KN, Guise TA and McCauley LK: Cancer to bone: a fatal attraction. Nat Rev Cancer 11: 411-425, 2011.